(c) 2024 PillSync.com

Citalopram 20 MG Oral Tablet

INDICATIONS AND USAGE Citalopram tablets USP are indicated for the treatment of depression. The efficacy of citalopram tablets USP in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the DSM-III and DSM-III-R category of Major Depressive Disorder (see CLINICAL PHARMACOLOGY ). A major depressive episode (DSM-IV) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. The antidepressant action of citalopram tablets USP in hospitalized depressed patients has not been adequately studied. The efficacy of citalopram tablets USP in maintaining an antidepressant response for up to 24 weeks following 6 to 8 weeks of acute treatment was demonstrated in two placebo-controlled trials (see CLINICAL PHARMACOLOGY ). Nevertheless, the physician who elects to use citalopram tablets USP for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.

Teva Pharmaceuticals USA Inc


6 years ago OVAL PINK 4741 9 3 Citalopram 20 MG Oral Tablet

OVAL PINK 4741 9 3

6 years ago OVAL PINK 4741 9 3 Citalopram 20 MG Oral Tablet

4741 9 3 OVAL PINK

HOW SUPPLIED Citalopram tablets USP are available as follows: 10 mg: light-beige, convex capsule-shaped, unscored tablets, debossed β€œ4740” on one side and β€œ93” on the other side containing citalopram hydrobromide USP equivalent to 10 mg citalopram, packaged in bottles of 100 (NDC 0093-4740-01) and 1000 (NDC 0093-4740-10) tablets and unit-dose boxes of 100 tablets (NDC 0093-4740-93). 20 mg: light-pink, convex capsule-shaped, scored tablets, debossed β€œ4741” on one side and β€œ9” score β€œ3” on the other side containing citalopram hydrobromide USP equivalent to 20 mg citalopram, packaged in bottles of 100 (NDC 0093-4741-01), 500 (NDC 0093-4741-05), and 5000 (NDC 0093-4741-50) tablets and unit-dose boxes of 100 tablets (NDC 0093-4741-93). 40 mg: white to off-white, convex capsule-shaped, scored tablets, debossed β€œ4742” on one side and β€œ9” score β€œ3” on the other side containing citalopram hydrobromide USP equivalent to 40 mg citalopram, packaged in bottles of 100 (NDC 0093-4742-01), 500 (NDC 0093-4742-05), and 5000 (NDC 0093-4742-50) tablets and unit-dose boxes of 100 tablets (NDC 0093-4742-93). Store at 20ΒΊ to 25ΒΊC (68ΒΊ to 77ΒΊF) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).


More pills like OVAL 4741 9 3

Related Pills

Citalopram 10 MG Oral Tablet

Teva Pharmaceuticals USA Inc












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site